CIAM
JSPR icon

Caitong International Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Caitong International Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2485
2025
Q3 		– Sell
-111
Closed -$616 – 2233
2025
Q2 		$616 Sell
111
-909
-89% -$4.47K ﹤0.01% 1672
2025
Q1 		$4.39K Buy
+1,020
New +$6.79K ﹤0.01% 1057

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Caitong International Asset Management's JSPR Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Jasper Therapeutics (JSPR) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in JSPR as recently as Q2 2025.

Caitong International Asset Management first reported a position in JSPR in Q1 2025 and has held it in 3 quarters since. The position peaked at $4.39K in Q1 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Caitong International Asset Management held 1 share of Jasper Therapeutics worth $1 as of Q1 2026.
  • Jasper Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2485 holding.
  • Caitong International Asset Management first reported a position in Jasper Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Jasper Therapeutics position peaked at $4.39K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.